Deirdre Jill Cohen - Concepedia

Author

Deirdre Jill Cohen

Also Known As

D Cohen, D J Cohen, D. Cohen, D. J. Cohen, D.J. Cohen, Deirdre Cohen, Deirdre J Cohen, Deirdre J. Cohen, Deirdre Jill Cohen, Pinar Gursoy

162

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

New York University Memorial Sloan Kettering Cancer Center University of Southern California University of Pittsburgh Medical Center Icahn School of Medicine at Mount Sinai

About

Deirdre Jill Cohen is an author at New York University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.6K
2	Health Sciences	10	10	745
3	Cell Biology	2	2	294
4	Clinical Immunology	1	1	10
5	Diagnostic Sciences	1	1	20

Deirdre Jill Cohen

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression Smruti Pushalkar, Mautin Hundeyin, Donnele Daley, Cancer Discovery	2018	1.3K
Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Journal of Clinical Oncology	2015	588
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer Daniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison, Journal of Clinical Oncology	2015	524
Computed Imaging Stereotaxy: Experience and Perspective Related to 500 Procedures Applied to Brain Masses Michael L.J. Apuzzo, Parakrama Chandrasoma, Deirdre Jill Cohen, Neurosurgery Brain MassesInterdisciplinary NeurosurgerySurgeryBrain LesionNeuro-oncology	1987	383
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer Wei Wang, Jill M. Marinis, Allison M. Beal, Cancer Cell Cancer ImmunosurveillancePancreatic CancerMedicineImmunologyTumor Immunity	2018	245
RETRACTED: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance Changhwan Yoon, Do Joong Park, Benjamin Schmidt, Clinical Cancer Research	2014	192
Prior Exposure to Medical and Dental X-rays Related to Tumors of the Parotid Gland1 Susan Preston‐Martin, Duncan C. Thomas, Stuart C. White, JNCI Journal of the National Cancer Institute	1988	143
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer Bert H. O’Neil, Aaron J. Scott, W.W. Ma, Annals of Oncology OncologyPancreatic CancerGastrointestinal OncologyGemcitabine Versus GemcitabineClinical Trials	2015	140
A Randomised Study of Whole-breast vs Tumour-bed Irradiation After Local Excision and Axillary Dissection for Early Breast Cancer David Dodwell, K. Dyker, Julia Brown, Clinical Oncology Surgical OncologyBreast OncologyRadiation TherapyMedicineBrachytherapy	2005	125
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer Lawrence Leichman, Susan Groshen, Bert H. O’Neil, The Oncologist	2016	73

Page 1